Citation Impact
Citing Papers
Pten Deficiency in Melanocytes Results in Resistance to Hair Graying and Susceptibility to Carcinogen-Induced Melanomagenesis
2008 StandoutNobel
Persistent Sexual Side Effects of Finasteride for Male Pattern Hair Loss
2011
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Endogenous Testosterone and Mortality in Men: A Systematic Review and Meta-Analysis
2011 Standout
β-Catenin Controls Hair Follicle Morphogenesis and Stem Cell Differentiation in the Skin
2001 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
PNU 157706, a novel dual type I and II5α-reductase inhibitor
1998
FCE 28260, a new 5α-reductase inhibitor: In vitro and in vivo effects
1996
Review of the role of androgenic hormones in the epidemiology of benign prostatc hyperplasia and prostate cancer
1994
Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
2004 Standout
Does long-term finasteride therapy affect the histologic features of benign prostatic tissue and prostate cancer on needle biopsy?
1999
Male Pattern Baldness and Coronary Heart Disease
2000
Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change
2003 Standout
The Use of Toxic Equivalency Factor Distributions in Probabilistic Risk Assessments for Dioxins, Furans, and PCBs
2003
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Organic Causes of Erectile Dysfunction in Men Under 40
2013 Standout
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction
1997 Standout
Design of the Prostate Cancer Prevention Trial (PCPT)
1995
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Interpreting the significance of changes in health-related quality-of-life scores.
1998 Standout
Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.
1993
Post-therapy Serum Prostate-Specific Antigen Level and Survival in Patients With Androgen-Independent Prostate Cancer
1999
Biomarker-based methods for determining noncompliance in a prevention trial
2002
Dihydrotestosterone and the Concept of 5α–Reductase Inhibition in Human Benign Prostatic Hyperplasia
2000
Clinical outcomes in heart failure: report from a community hospital-based registry
1999
Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
2013 Standout
Interpretation of quality of life changes
1993
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial
1998
Chemoprevention of cancer
1994
The Prostate Cancer Prevention Trial: design, status, and promise
2003
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Drug-induced heart failure
1999
Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men
2002
The Influence of Finasteride on the Development of Prostate Cancer
2003 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
The Year in Non–ST-Segment Elevation Acute Coronary Syndrome
2010
Safety of Anacetrapib in Patients with or at High Risk for Coronary Heart Disease
2010
Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study
2002 Standout
ANDROGEN METABOLISM AS IT AFFECTS HAIR GROWTH IN ANDROGENETIC ALOPECIA
1996
Procyanidin Oligomers Selectively and Intensively Promote Proliferation of Mouse Hair Epithelial Cells In Vitro and Activate Hair Follicle Growth In Vivo11The authors disclosed conflict of interest.
1999
A brief male sexual function inventory for urology
1995
Myocarditis
2000 Standout
The Biology of Hair Follicles
1999 Standout
Capturing and profiling adult hair follicle stem cells
2004 Standout
Angiotensin‐Converting Enzyme Inhibitor Use in Older Patients with Heart Failure and Renal Dysfunction
1999
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2006
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Immunohistochemical evidence for differential distribution of 5α-reductase isoenzymes in human skin
1995
Systolic versus diastolic heart failure in community practice: clinical features, outcomes, and the use of angiotensin-converting enzyme inhibitors
2000
Cardiology or Primary Care for Heart Failure in the Community Setting
1999
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
The 2005 World Health Organization Reevaluation of Human and Mammalian Toxic Equivalency Factors for Dioxins and Dioxin-Like Compounds
2006 Standout
The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia
1998
Novel aromatase and 5α-reductase inhibitors
1994
Copper-Mediated Coupling Reactions and Their Applications in Natural Products and Designed Biomolecules Synthesis
2008 Standout
New Approaches to Antiglaucoma Therapy
1997
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design
2018 Standout
A Prospective Evaluation of Plasma Prostate-Specific Antigen for Detection of Prostatic Cancer
1995
Testosterone Treatment and Mortality in Men with Low Testosterone Levels
2012 Standout
Molecular Biology of the Androgen Receptor
2002
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
2012 Standout
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
1998 StandoutScience
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Prevention of Hormone-Related Cancers: Prostate Cancer
2005
A Scaleable Synthesis of Dutasteride: A Selective 5α-Reductase Inhibitor
2007
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review)
2014
Controls of Hair Follicle Cycling
2001 Standout
The Control of Prostate-Specific Antigen Expression and Gene Regulation by Pharmacological Agents
2001
The Metabolic Syndrome
2008 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
2012 Standout
An observational retrospective evaluation of 79 young men with long‐term adverse effects after use of finasteride against androgenetic alopecia
2016
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Molecular profiling of human prostate tissues: insights into gene expression patterns of prostate development during puberty
2004
Global cancer statistics, 2012
2015 Standout
Gender Differences in the Regulation of Blood Pressure
2001
A Pilot Trial of CTLA-4 Blockade with Human Anti-CTLA-4 in Patients with Hormone-Refractory Prostate Cancer
2007 StandoutNobel
Role of Hormones in Pilosebaceous Unit Development
2000
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
1999
Works of Bruce Binkowitz being referenced
Finasteride in the treatment of men with androgenetic alopecia
1998
Assessment of systemic effects of different ophthalmic β-blockers in healthy volunteers
1991
The Effect of Finasteride in Men with Benign Prostatic Hyperplasia
1992
Effects of finasteride on health-related quality of life in men with symptomatic benign prostatic hyperplasia
1996
Disparity in Quantitative Risk Assessment: A Review of Input Distributions
2001
PCPT: Evidence That Finasteride Reduces Risk of Most Frequently Detected Intermediate- and High-grade (Gleason Score 6 and 7) Cancer
2009
Design of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib
2009
Assessment of bronchial effects following topical administration of butylamino‐phenoxy‐propanol‐acetate, an oculoselective beta‐ adrenoceptor blocker in asthmatic subjects.
1992
The effect of finasteride in men with benign prostatic hyperplasia
2002